AstraZeneca AB

Case [2012] APO 125


IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

AstraZeneca AB [2012] APO 125

Patent Application:                   2012201783

Title:Chemical process for preparation of aromatic cyclopropane esters and amides

Patent Applicant:  AstraZeneca AB

Delegate:  E J Knock

Decision Date:  2 November 2012

Catchwords:  PATENTS – examiner objection – case management of divisional applications – no response by applicant – application refused

Representation:  Patent applicant:  Michael Caine, Davies Collison Cave, Melbourne

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                   2012201783

Title:Chemical process for preparation of aromatic cyclopropane esters and amides

Patent Applicant:  AstraZeneca AB

Date of Decision:  2 November 2012

DECISION

I refuse the application.

REASONS FOR DECISION

Patent application 2012201783 was filed by AstraZeneca AB, as a divisional of application 2007282181 on 27 March 2012.  An examination report issued on 18 June 2012, raising five objections.  In line with the Commissioner's approach to case management of divisionals, the report included the following objection:

“Objection(s) 1-4 of my report are based on the same grounds objected to in the examination of patent application 2007282181. Please note that if a response overcoming this objection is not filed within two months of the date of this report the Commissioner will consider whether to direct amendment of the application under section 107 or proceed to refuse the application under section 49(2) of the Act. If intending to proceed under either of these provisions the Commissioner will notify you in writing and indicate the time and place you may be heard on the matter. In deciding the matter the Commissioner will consider all possible grounds of objection to the application not only those identified below.

As no reply was received, the Commissioner issued a hearing notice in the following terms:

"The examination report of 18 June 2012 raised an objection(s) equivalent to that in the parent application.  In line with our approach to case management of divisionals, you were given two months to respond to that report.  As no response has been received, the matter will now be set for hearing.

I believe that it is possible to hear this matter on the basis of written submissions, so I allow you one (1) month from the date of this letter to file any submissions you wish.  Your submissions should address the ground(s) of objection identified in the examination report.  Once your submissions have been received, or alternatively if no submissions are received, the matter will be passed to a hearing officer to issue a written decision.  Please note that it is possible for the Commissioner to refuse the application or direct amendment.

Alternatively, if you file amendments overcoming the objection(s) within this period, the Commissioner will not proceed with the hearing.  However, if the amendments do not fully overcome the objection(s), you will be advised of this fact and the hearing may continue as above."

The applicant has not provided any submissions.

The objection

I have reviewed the examiner's report, and I agree that there are appropriately raised objections.  The applicant has chosen not to defend the application.  They have provided no submissions disputing the objections, and have not proposed any amendment to attempt to overcome the objections.  In these circumstances there are no reasonable prospects of the applicant overcoming the objections.  The application should be refused.

E J Knock
Delegate of the Commissioner of Patents

Details
AGLC
AstraZeneca AB [2012] APO 125
Case
[2012] APO 125
Decision Date

CaseChat Overview and Summary

The matter before the Australian Patent Office was a patent application by AstraZeneca AB, seeking to patent a chemical process for the preparation of aromatic cyclopropane esters and amides. The application was a divisional of an earlier application and was filed on 27 March 2012. The Commissioner issued an examination report on 18 June 2012, raising five objections to the patentability of the invention. The applicant did not respond to the examination report within the required timeframe, leading to the Commissioner issuing a hearing notice allowing the applicant one month to file submissions or amendments in response to the objections. The applicant failed to respond within the given period, leading to the Commissioner issuing a decision to refuse the application. The legal issue before the Commissioner was whether the objections raised in the examination report were valid and whether there were reasonable prospects of the applicant overcoming the objections. The Commissioner found that the objections were valid and that there were no reasonable prospects of the applicant overcoming the objections as they had failed to provide any submissions or amendments in response to the objections. Therefore, the Commissioner decided to refuse the application. The final orders of the Commissioner were to refuse the application and to inform the applicant of their right to appeal the decision to the Federal Court of Australia.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.